Important Notice: Our web hosting provider recently started charging us for additional visits, which was unexpected. In response, we're seeking donations. Depending on the situation, we may explore different monetization options for our Community and Expert Contributors. It's crucial to provide more returns for their expertise and offer more Expert Validated Answers or AI Validated Answers. Learn more about our hosting issue here.

How to establish level A IVIVC for BCS class II IR products where in vitro time points are not the same as in vivi time points?

0
Posted

How to establish level A IVIVC for BCS class II IR products where in vitro time points are not the same as in vivi time points?

0

SD: Mathematically, the different in vitro dissolution time points & in vivo absorption time points may be correlated using time-scaling parameters. However, some points about developing an IVIVC for an IR product should be noted: (1) IVIVC is applicable for extended release products where drug absorption is dissolution-rate limited; (2) in order to establish an IVIVC one would ideally require formulations that have sufficiently different release rates that result in different rates &/or durations of absorption. Although Class II compounds may have low solubility and therefore absorption may be dissolution-rate limited, the different “IR” formulations would all, theoretically, release drug within ~1 hour. Therefore, in vivo dissolution would be dependent largely on the drug molecule physico-chemical properties & not the formulation. Therefore, one would not expect to see sufficiently different absorption profiles that will permit the development of an IVIVC.

Related Questions

What is your question?

*Sadly, we had to bring back ads too. Hopefully more targeted.

Experts123